Cargando…

Digital Technologies: Advancing Individualized Treatments through Gene and Cell Therapies, Pharmacogenetics, and Disease Detection and Diagnostics

Digital technologies are shifting the paradigm of medicine in a way that will transform the healthcare industry. Conventional medical approaches focus on treating symptoms and ailments for large groups of people. These approaches can elicit differences in treatment responses and adverse reactions ba...

Descripción completa

Detalles Bibliográficos
Autores principales: Corridon, Peter R., Wang, Xinyu, Shakeel, Adeeba, Chan, Vincent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599083/
https://www.ncbi.nlm.nih.gov/pubmed/36289707
http://dx.doi.org/10.3390/biomedicines10102445
_version_ 1784816508037234688
author Corridon, Peter R.
Wang, Xinyu
Shakeel, Adeeba
Chan, Vincent
author_facet Corridon, Peter R.
Wang, Xinyu
Shakeel, Adeeba
Chan, Vincent
author_sort Corridon, Peter R.
collection PubMed
description Digital technologies are shifting the paradigm of medicine in a way that will transform the healthcare industry. Conventional medical approaches focus on treating symptoms and ailments for large groups of people. These approaches can elicit differences in treatment responses and adverse reactions based on population variations, and are often incapable of treating the inherent pathophysiology of the medical conditions. Advances in genetics and engineering are improving healthcare via individualized treatments that include gene and cell therapies, pharmacogenetics, disease detection, and diagnostics. This paper highlights ways that artificial intelligence can help usher in an age of personalized medicine.
format Online
Article
Text
id pubmed-9599083
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-95990832022-10-27 Digital Technologies: Advancing Individualized Treatments through Gene and Cell Therapies, Pharmacogenetics, and Disease Detection and Diagnostics Corridon, Peter R. Wang, Xinyu Shakeel, Adeeba Chan, Vincent Biomedicines Perspective Digital technologies are shifting the paradigm of medicine in a way that will transform the healthcare industry. Conventional medical approaches focus on treating symptoms and ailments for large groups of people. These approaches can elicit differences in treatment responses and adverse reactions based on population variations, and are often incapable of treating the inherent pathophysiology of the medical conditions. Advances in genetics and engineering are improving healthcare via individualized treatments that include gene and cell therapies, pharmacogenetics, disease detection, and diagnostics. This paper highlights ways that artificial intelligence can help usher in an age of personalized medicine. MDPI 2022-09-30 /pmc/articles/PMC9599083/ /pubmed/36289707 http://dx.doi.org/10.3390/biomedicines10102445 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Perspective
Corridon, Peter R.
Wang, Xinyu
Shakeel, Adeeba
Chan, Vincent
Digital Technologies: Advancing Individualized Treatments through Gene and Cell Therapies, Pharmacogenetics, and Disease Detection and Diagnostics
title Digital Technologies: Advancing Individualized Treatments through Gene and Cell Therapies, Pharmacogenetics, and Disease Detection and Diagnostics
title_full Digital Technologies: Advancing Individualized Treatments through Gene and Cell Therapies, Pharmacogenetics, and Disease Detection and Diagnostics
title_fullStr Digital Technologies: Advancing Individualized Treatments through Gene and Cell Therapies, Pharmacogenetics, and Disease Detection and Diagnostics
title_full_unstemmed Digital Technologies: Advancing Individualized Treatments through Gene and Cell Therapies, Pharmacogenetics, and Disease Detection and Diagnostics
title_short Digital Technologies: Advancing Individualized Treatments through Gene and Cell Therapies, Pharmacogenetics, and Disease Detection and Diagnostics
title_sort digital technologies: advancing individualized treatments through gene and cell therapies, pharmacogenetics, and disease detection and diagnostics
topic Perspective
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599083/
https://www.ncbi.nlm.nih.gov/pubmed/36289707
http://dx.doi.org/10.3390/biomedicines10102445
work_keys_str_mv AT corridonpeterr digitaltechnologiesadvancingindividualizedtreatmentsthroughgeneandcelltherapiespharmacogeneticsanddiseasedetectionanddiagnostics
AT wangxinyu digitaltechnologiesadvancingindividualizedtreatmentsthroughgeneandcelltherapiespharmacogeneticsanddiseasedetectionanddiagnostics
AT shakeeladeeba digitaltechnologiesadvancingindividualizedtreatmentsthroughgeneandcelltherapiespharmacogeneticsanddiseasedetectionanddiagnostics
AT chanvincent digitaltechnologiesadvancingindividualizedtreatmentsthroughgeneandcelltherapiespharmacogeneticsanddiseasedetectionanddiagnostics